TriMix
Lipid Nanoparticles
Oncolysis
Tumor microenvironment modulating technology
Melanoma
HPV+ cancer
Kidney cancer
Other indications
eTheRNA is developing mRNA-based products mimicking the action of oncolytic viruses.
LEARN MOREeTheRNA has formed a consortium with North American and European partners to access tools to develop a novel mRNA vaccine against SARS-CoV-2.
LEARN MOREGalileilaan 19, 2845 Niel, Belgium
+32 3 369 17 40
© 2020 Etherna | Studio Hanswijk
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.